ConductScience.org, home

Library / Genes

CD247: CD247 molecule

1 protein, 691 patents, 0 drugs, 0 trials, 3,933 NIH grants and 7,732 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCD247HGNC
NameCD247 moleculeHGNC
NCBI Gene ID919NCBI Gene
HGNC IDHGNC:1677HGNC
EnsemblENSG00000198821NCBI Gene
AliasesCD3-ZETA, CD3H, CD3Q, CD3Z, CD3ZETA, IMD25, T3Z, TCRZNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P20963T-cell surface glycoprotein CD3 zeta chain16438Ensembl, GeneID, HGNCUniProt

Patents 691

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4806462 A22026-09-161P20963Espacenet
EP 4801643 A12026-09-0927P20963Espacenet
EP 4801963 A12026-09-09138P20963Espacenet
EP 4795154 A12026-08-2643P20963Espacenet
WO 2026167227 A12026-08-133P20963Espacenet
EP 4774292 A12026-07-15276P20963Espacenet
EP 4763220 A22026-06-24121P20963Espacenet
EP 4758171 A12026-06-178P20963Espacenet
EP 4752227 A22026-06-0312P20963Espacenet
JP 2026090319 A2026-06-02292P20963Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3933

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant1212,025NIH's project files
P30CA016672Cancer Center Support Grant662,025NIH's project files
P50CA126752SPORE in Lymphoma392,025NIH's project files
P30CA016520Abramson Cancer Center Support Grant352,025NIH's project files
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant322,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant252,025NIH's project files
T32HL092332Training In Cell and Gene Therapy252,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)242,025NIH's project files
P30CA033572Cancer Center Support Grant232,025NIH's project files
R01CA114536Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy192,025NIH's project files

Papers 7732

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42801642PubTator, text miningPubMed
42792667PubTator, text miningPubMed
42759984PubTator, text miningPubMed
42750004PubTator, text miningPubMed
42729209PubTator, text miningPubMed
42706722PubTator, text miningPubMed
42679935PubTator, text miningPubMed
42620173PubTator, text miningPubMed
42607060PubTator, text miningPubMed
42603278PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license